136.95
1.96%
+2.63
After Hours:
136.95
Masimo Corp stock is currently priced at $136.95, with a 24-hour trading volume of 315.79K.
It has seen a +1.96% increased in the last 24 hours and a +1.50% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $134.6 pivot point. If it approaches the $137.9 resistance level, significant changes may occur.
Masimo Corp Stock (MASI) Financials Data
Masimo Corp (MASI) Revenue 2024
MASI reported a revenue (TTM) of $2.05 billion for the quarter ending December 31, 2023, a +0.60% rise year-over-year.
Masimo Corp (MASI) Net Income 2024
MASI net income (TTM) was $81.50 million for the quarter ending December 31, 2023, a -43.21% decrease year-over-year.
Masimo Corp (MASI) Cash Flow 2024
MASI recorded a free cash flow (TTM) of $6.40 million for the quarter ending December 31, 2023, a +123.79% increase year-over-year.
Masimo Corp (MASI) Earnings per Share 2024
MASI earnings per share (TTM) was $1.51 for the quarter ending December 31, 2023, a -41.70% decline year-over-year.
Masimo Corp Stock (MASI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
KIANI JOE E | CEO and Chairman of the Board |
May 25 '23 |
Buy |
157.16 |
6,365 |
1,000,342 |
366,055 |
Masimo Corp Stock (MASI) Latest News
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research
Reasons Why You Should Retain Masimo (MASI) Stock for Now
Zacks Investment Research
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
Zacks Investment Research
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
Zacks Investment Research
Forecasting The Future: 6 Analyst Projections For Masimo
Benzinga
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga
About Masimo Corp
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation has a strategic partnership with NU Hospitals. The company was founded in 1989 and is headquartered in Irvine, California.
Cap:
|
Volume (24h):